Interstitial lung disease with statin-associated necrotizing autoimmune myopathy responding to rituximab

Arch Bronconeumol. 2016 Jul;52(7):395-7. doi: 10.1016/j.arbres.2015.10.011. Epub 2015 Dec 29.

[Article in English, Spanish]

Authors

Olívia Meira Dias¹, Bruno Guedes Baldi², André Nathan Costa², Samuel Katsuyuki Shinjo³, Renata Miossi³, Ronaldo Adib Kairalla²

Affiliations

¹ División Pulmonar, Heart Institute, University of São Paulo, São Paulo, Brasil. Electronic address: meiradias@yahoo.com.br.
² División Pulmonar, Heart Institute, University of São Paulo, São Paulo, Brasil.
³ División de Reumatología, Hospital das Clínicas, University of São Paulo, São Paulo, Brasil.

PMID: 26744248
DOI: 10.1016/j.arbres.2015.10.011

No abstract available

Publication types

Case Reports

MeSH terms

Autoimmune Diseases / chemically induced*
Autoimmune Diseases / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Immunosuppressive Agents / therapeutic use*
Lung Diseases, Interstitial / chemically induced*
Lung Diseases, Interstitial / diagnostic imaging
Lung Diseases, Interstitial / drug therapy
Male
Middle Aged
Models, Immunological
Myalgia / chemically induced*
Myalgia / drug therapy
Necrosis
Rituximab / therapeutic use*
Rosuvastatin Calcium / adverse effects*
Tomography, X-Ray Computed

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Rituximab
Rosuvastatin Calcium